13F
中

PAHC PHIBRO ANIMAL HEALTH CORP-A

2026Q1 · CUSIP 71742Q106 · Sector: Healthcare & Biotech

Lit · Institutions accelerating in
Holders
255
Δ holders QoQ
+30
Breadth percentile
Top 10%
Whale holders
132
Δ whales
+20
Inst. holding value
$1.1B
New positions
62
Closed positions
32
Price momentum (1Q)
-34.5%
Put / Call
2/2

Breadth history (34 quarters)

2018Q1: Δ+3 · h=170 2018Q2: Δ+3 · h=173 2018Q3: Δ+18 · h=191 2018Q4: Δ-3 · h=188 2019Q1: Δ-14 · h=174 2019Q2: Δ-10 · h=164 2019Q3: Δ-13 · h=151 2019Q4: Δ+0 · h=151 2020Q1: Δ+1 · h=152 2020Q2: Δ-1 · h=151 2020Q3: Δ-16 · h=135 2020Q4: Δ+1 · h=136 2021Q1: Δ+3 · h=139 2021Q2: Δ+6 · h=145 2021Q3: Δ-4 · h=141 2021Q4: Δ+1 · h=142 2022Q1: Δ+9 · h=151 2022Q2: Δ-3 · h=148 2022Q3: Δ+4 · h=152 2022Q4: Δ-19 · h=133 2023Q1: Δ-1 · h=132 2023Q2: Δ-1 · h=131 2023Q3: Δ-5 · h=126 2023Q4: Δ+10 · h=136 2024Q1: Δ+3 · h=139 2024Q2: Δ+3 · h=142 2024Q3: Δ+5 · h=147 2024Q4: Δ+26 · h=173 2025Q1: Δ+12 · h=185 2025Q2: Δ+11 · h=196 2025Q3: Δ+20 · h=216 2025Q4: Δ+9 · h=225 2026Q1: Δ+30 · h=255 2018Q1: holders=170 2018Q2: holders=173 2018Q3: holders=191 2018Q4: holders=188 2019Q1: holders=174 2019Q2: holders=164 2019Q3: holders=151 2019Q4: holders=151 2020Q1: holders=152 2020Q2: holders=151 2020Q3: holders=135 2020Q4: holders=136 2021Q1: holders=139 2021Q2: holders=145 2021Q3: holders=141 2021Q4: holders=142 2022Q1: holders=151 2022Q2: holders=148 2022Q3: holders=152 2022Q4: holders=133 2023Q1: holders=132 2023Q2: holders=131 2023Q3: holders=126 2023Q4: holders=136 2024Q1: holders=139 2024Q2: holders=142 2024Q3: holders=147 2024Q4: holders=173 2025Q1: holders=185 2025Q2: holders=196 2025Q3: holders=216 2025Q4: holders=225 2026Q1: holders=255 -30 -15 +0 +15 +30 113191268 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 3 lit events

Period Percentile Next-1Q return Next-2Q return
2026Q1 Top 10% — —
2025Q3 Top 16% +15.4% -24.6%
2018Q3 Top 12% -12.3% -14.8%

Options Sentiment

Put holders
2
QoQ: 0
Call holders
2
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
14.0
EPS (TTM)
$2.34
EPS YoY
+200.0%
Revenue (TTM)
$1.5B
Revenue YoY
+26.0%
Quarterly Revenue & EPS (4Y)
2022-06-30: $255M 2022-09-30: $233M 2022-12-31: $245M 2023-03-31: $246M 2023-06-30: $255M 2023-09-30: $231M 2023-12-31: $250M 2024-03-31: $263M 2024-06-30: $273M 2024-09-30: $260M 2024-12-31: $309M 2025-03-31: $348M 2025-06-30: $379M 2025-09-30: $364M 2025-12-31: $374M 2026-03-31: $384M 2022-06-30: EPS 0.18 2022-09-30: EPS 0.10 2022-12-31: EPS 0.18 2023-03-31: EPS 0.25 2023-06-30: EPS 0.28 2023-09-30: EPS -0.20 2023-12-31: EPS 0.03 2024-03-31: EPS 0.21 2024-06-30: EPS 0.02 2024-09-30: EPS 0.17 2024-12-31: EPS 0.08 2025-03-31: EPS 0.51 2025-06-30: EPS 0.43 2025-09-30: EPS 0.65 2025-12-31: EPS 0.67 2026-03-31: EPS 0.59 0M 192M 384M $M -0.22 0.26 0.74 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 27 2023-03-31: PE 18.32023-06-30: PE 17.42023-09-30: PE 19.42023-12-31: PE 31.92024-03-31: PE 55.22024-06-30: PE 290.92024-09-30: PE 55.32024-12-31: PE 52.52025-03-31: PE 30.22025-06-30: PE 25.52025-09-30: PE 26.82025-12-31: PE 232026-03-31: PE 14.6 13 159 305 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)